The Scientist

» embryonic stem cells and disease/medicine

Most Recent

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Second Victim of Hantavirus

Second Victim of Hantavirus

By | August 28, 2012

Another person has died from the rodent-borne disease after visiting Yosemite National Park.

0 Comments

image: Stem Cell Research Funding Upheld

Stem Cell Research Funding Upheld

By | August 27, 2012

A US Appeal court rules that the National Institutes of Health is legally allowed to fund human embryonic stem cell research.

0 Comments

image: Texan West Nile Concerns

Texan West Nile Concerns

By | August 27, 2012

Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.

0 Comments

image: Blood Spots Are Epigenetic Time Capsules

Blood Spots Are Epigenetic Time Capsules

By | August 22, 2012

Researchers show that blood spotted onto Guthrie cards, usually at birth, can be a high quality source of methylated DNA for long-term epigenetic studies.

0 Comments

image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.

3 Comments

image: Embryonic Stem Cells Survive Freezing

Embryonic Stem Cells Survive Freezing

By | August 16, 2012

Even after 18 years of frozen storage, human embryos can still produce viable stem cells for drug screening and biomedical research.

0 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech